Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Providencia rettgeri

Identifiers: BioSample: SAMN04014923; Sample name: FDA-CDC-AR_0082; SRA: SRS1256917

Organism: Providencia rettgeri
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Morganellaceae; Providencia

Attributes

BioProject: PRJNA292904 Gram Negative Carbapenemase Detection Genome sequencing and assembly
Retrieve all samples from this project

Submission: Centers for Disease Control and Prevention, Brian Yoo; 2015-08-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	susceptible	==	2	mg/L	MIC	CLSI
amoxicillin-clavulanic acid	resistant	>	32/16	mg/L	MIC	CLSI
ampicillin	resistant	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	resistant	>	32/16	mg/L	MIC	CLSI
aztreonam	resistant	==	64	mg/L	MIC	CLSI
cefazolin	resistant	>	8	mg/L	MIC	CLSI
cefepime	susceptible	==	1	mg/L	MIC	CLSI
cefotaxime	resistant	>	64	mg/L	MIC	CLSI
cefoxitin	intermediate	==	16	mg/L	MIC	CLSI
ceftazidime	resistant	>	128	mg/L	MIC	CLSI
ceftriaxone	resistant	>	32	mg/L	MIC	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	CLSI
colistin	not defined	==	4	mg/L	MIC	CLSI
doripenem	resistant	>	8	mg/L	MIC	CLSI
ertapenem	resistant	==	8	mg/L	MIC	CLSI
gentamicin	susceptible	==	0.5	mg/L	MIC	CLSI
imipenem	resistant	==	32	mg/L	MIC	CLSI
levofloxacin	susceptible	==	0.25	mg/L	MIC	CLSI
meropenem	resistant	==	8	mg/L	MIC	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	CLSI
polymyxin B	not defined	==	4	mg/L	MIC	CLSI
tetracycline	resistant	==	32	mg/L	MIC	CLSI
tigecycline	resistant	>	4	mg/L	MIC	CLSI
tobramycin	susceptible	==	1	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	resistant	>	8/152	mg/L	MIC	CLSI